Insider Cluster (2 insiders) ·Filed Aug 14, 2026

LGND

LIGAND PHARMACEUTICALS INC
NEUTRAL
Impact 4/10
Horizondays Processed1mo ago
Insider cluster: 2 insiders, $11.3M total
Actionable Insight • Neutral

The cluster is consistent with routine post-earnings option exercise and diversification by two insiders. The $9.24M CFO sale is notable in absolute size but immaterial relative to the $5.8B market cap. No bearish signal — monitor for any additional insider sales in the next 30 days that would break the pattern of single-day post-vesting liquidity.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d
LGND ▼ -5.07% at T+20d
NEUTRAL call ✗ call lost -5.07% · α vs SPY -3.09% · entry $291.77 → $276.98
Next anchor: T+60d in 5w
Latest observation: T+31 -0.77% FF3 residual α
Entry anchored
Aug 14, 2026
via day open
T+1d
-1.43%
call -1.43% · α -0.76%
$287.59
settled 7w ago
T+5d
-3.97%
call -3.97% · α -2.78%
$280.18
settled 6w ago
T+20d
-5.07%
call -5.07% · α -3.09%
$276.98
settled 18d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

CFO Octavio Espinoza and Director Jason Haas executed a cluster of derivative exercises and open-market sales on August 12, 2026, totaling $11.33M in gross proceeds. The sales follow Ligand's strong Q2 2026 earnings beat (EPS $2.37 vs $1.97 consensus) and the close of the XOMA Royalty acquisition, suggesting post-earnings liquidity and tax planning rather than a bearish signal. The $9.24M CFO sale is large in absolute terms but represents only ~0.16% of the $5.8B market cap, falling within the modest proportionality band, and the cluster is dominated by sales with no buys, consistent with routine post-vesting diversification.

Key Financial Metrics

Direction
selling
Total Value
$11.3M
Insiders
2

Key Facts

  • CFO Espinoza sold 31,641 shares at ~$292.07 for $9.24M on 2026-08-12
  • Director Haas sold 7,138 shares at ~$292.81 for $2.09M on 2026-08-12
  • All sales were preceded by derivative exercises at $0 or low strike prices, indicating option cashless exercises
  • Total cluster value of $11.33M is ~0.2% of LGND's $5.8B market cap
  • Cluster occurred 6 days after Q2 2026 earnings beat and guidance raise on 2026-08-06

Financial Impact

Total insider sales of $11.33M represent ~0.2% of market cap, within the modest proportionality band

insider ownershipfloat

Risk Factors

  • Further insider selling in coming weeks could indicate a shift in sentiment
  • The stock has rallied significantly post-earnings (implied by sale price ~$292 vs prior levels), increasing the risk of a pullback

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
93% bullish (15 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-LGND-1786741562872
10 reports for LGND
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+60▲ +38.85%Apr 14, 2026
Filters
Rows
Reports for LGND — sortable, filterable
TypeNow
Sep 14, 2026
17d ago
Insider Cluster
NEUTRAL ★ 3/10
$276.98 $298.50▲ +7.77%▲ +5.66%$302.96 (+9.38%)
Aug 14, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$291.77 $280.18▼ −3.97%▼ −2.78%$302.96 (+3.84%)
Aug 6, 2026
8w ago
8-K
BULLISH ★ 7/10
$300.14 $288.82▼ −3.77%▼ −4.98%$302.96 (+0.94%)
Jun 25, 2026
14w ago
8-K
MIXED ★ 6/10
$303.59 $319.55▲ +5.26%▲ +3.09%$302.96 (−0.21%)
Jun 18, 2026
15w ago
Insider Cluster
NEUTRAL ★ 3/10
$274.88 $295.92▲ +7.65%▲ +9.32%$302.96 (+10.22%)
Jun 16, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$255.25 $279.44▲ +9.48%▲ +11.71%$302.96 (+18.69%)
Jun 12, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$253.25 $262.17▲ +3.52%▲ +4.91%$302.96 (+19.63%)
May 1, 2026
22w ago
Insider Cluster
NEUTRAL ★ 3/10
$227.44 $221.41▼ −2.65%▼ −5.00%$302.96 (+33.20%)
Apr 14, 2026
24w ago
Press Release
BULLISH ★ 8/10
$232.34 $226.67▼ −2.44%▼ −3.83%$302.96 (+30.40%)
Feb 26, 2026
31w ago
8-K
BULLISH ★ 8/10
$196.17 $206.27▲ +5.15%▲ +6.28%$302.96 (+54.44%)
Showing 10 of 10

US Market Status

Market Closed — Opens Mon (65h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 14, 2026